Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.
about
New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?IGF-1/IGFBP-1 increases blastocyst formation and total blastocyst cell number in mouse embryo culture and facilitates the establishment of a stem-cell lineRevisiting ovarian hyper stimulation syndrome: Towards OHSS free clinicPregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage.Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter.Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience.Severe ovarian hyperstimulation syndrome leading to ICU admissionOvarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome.Co action of CFTR and AQP1 increases permeability of peritoneal epithelial cells on estrogen-induced ovarian hyper stimulation syndrome.Treatment results of high dose cabergoline as an adjuvant therapy in six patients with established severe ovarian hyper stimulation syndrome.Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome--a preliminary proof of conceptOutpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort studyThe pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndromeMinimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine inseminationTargeted single molecule sequencing methodology for ovarian hyperstimulation syndromeCould pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian hyperstimulation syndrome in the IVF/ICSI procedure?Ovarian hyperstimulation syndrome.Radiological illustration of spontaneous ovarian hyperstimulation syndrome.Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.Hematocrit as a simple method to predict and manage ovarian hyperstimulation syndrome in assisted reproduction.Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.An IVF fallacy: multiple pregnancy risk is lower for older women.Comparison of cryopreservation outcome following intracytoplasmic sperm injection and conventional in vitro fertilizationEstradiol level on day 9 as a predictor of risk for ovarian hyperresponse during controlled ovarian hyperstimulationUse of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalizationA prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience.Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study.Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan.Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main StudyOvarian Hyperstimulation Syndrome with pleural effusion: a case report.Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatmentAssociation between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.Male sexual dysfunction and infertility associated with neurological disorders.
P2860
Q24629517-37EA030A-1C4F-4495-91B5-26B17675D7BEQ24805894-B1DBC5B8-B9DD-4A60-809F-45DF9F5DFD3EQ28084432-C7F35B07-9E04-4671-9421-6E58419A50E2Q33675214-8E7E5751-E7B6-4B68-8BB2-CAF99AC86E75Q33860349-BEA633AF-FF7C-4D52-9D21-45C2D14BEC62Q33897147-0D206650-21D5-44DD-BB0F-9FA3899651C4Q33975003-2F95A632-35D4-473C-A1AC-0AAE5C161C86Q34249374-E1F37919-BF5C-4BF0-B52C-B2A4436F1CC4Q34330406-C6743DE0-525E-4023-BBF8-9E819E934F01Q34396485-25D04550-81B3-4CA7-9DE6-7A8E700E0C4AQ34589550-5F48E69B-DDB8-4557-99D9-5709AF2386A1Q34631171-D248FF1A-51B1-41F2-B605-3CD8BD29D115Q34641919-C1A2B49C-E1C8-4D6B-AC60-85A8BF8610E5Q35071420-A5B4B987-0146-4B4C-AFF8-53BA49DFA363Q35086106-9DE34051-F944-4E4B-9469-07936B2C5728Q35424851-6C942026-E374-411E-9A80-290A32CE7990Q35481149-BF5804CB-9677-4056-AC68-63CA4F7E49DBQ35493429-C03C7D61-17AD-4F30-98D6-9410A6CCD046Q35564839-EF866CF8-77E8-4918-B608-34F4DE5FF66AQ35621462-E373E313-3E5B-4128-AA98-3DB8BD7E6057Q35770019-D5502BF4-4CAD-40B3-81CC-1261FE5B0EC6Q35898934-DD150FD1-CD33-481A-A5C4-F7C35F83176AQ36045426-EB9BD5FB-715C-45B3-8B05-246A9611595FQ36060453-3F8F58A0-A512-4DF1-B04D-B058A1351DD2Q36112513-350713D8-EA7A-4A23-91B1-E7A19DD63052Q36267371-33352B51-E812-43EA-9E59-29AD4B8A880BQ36267809-A09FCA1A-F213-4EBF-A940-EC723409AD9BQ36270005-BAAB8D76-2768-43A1-8D93-B02D6E6FB622Q36270296-982F9B9D-1496-4788-B828-F600953D9869Q36270400-9F289CE5-CE5F-44BE-94A7-839DB71C86B7Q36271281-6E28CC4B-5C20-46D2-AD2D-3BB2AECA0264Q36385538-404399F5-28D9-43AA-A2BF-7B3B8D729A06Q36694714-134DD5C5-C686-4047-8F1F-A06B970E2616Q36926487-E8376AE8-474A-4411-8BE6-BC4EF044B739Q36963947-864F924F-A5F0-4094-A0DC-0B37D7F1527FQ36994477-77847997-3583-4CAE-863A-B6DA0E60C636Q36999626-A6FBBBBE-D233-4E63-9101-B0E296D67870Q37037279-F6814750-96B8-4DEA-91B3-AB1747BB356AQ37056654-C2A0D23F-1ED4-4B34-A9AD-DF942EBB6C7DQ37074577-D9B6CA8E-5525-474D-ABD2-3A4E58214945
P2860
Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@ast
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@en
type
label
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@ast
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@en
prefLabel
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@ast
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@en
P2093
P1476
Ovarian hyperstimulation syndr ...... ies: prevention and treatment.
@en
P2093
P304
P407
P577
1992-08-01T00:00:00Z